Association of intraoperative opioids with improved recurrence-free survival in triple-negative breast cancer.

被引：0
|
作者：
Montagna, Giacomo
Hannum, Margaret L.
Tan, Kay See
Plitas, George
McCormick, Patrick J.
Fischer, Gregory W.
Morrow, Monica
Mincer, Joshua S.
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Biostat Serv, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Dept Anesthesiol & Crit Care Med, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
542
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The association of metabolic syndrome with triple-negative breast cancer
    Maiti, B.
    Kundranda, M. N.
    Spiro, T. P.
    Daw, H. A.
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 121 (02) : 479 - 483
  • [42] Association of cytoplasmic HMGB1 (cHMGB1) expression with local tumor recurrence in triple-negative breast cancer.
    Oliveira, Iandra Freire
    Rocha, Jhonata Lima
    Pereira, Anamaria Falcao
    Silva Lopes, Marina Helena
    Cajado, Aurilene Gomes
    Sant'Ana, Rosane Oliveira
    Carvalho Almeida, Paulo Roberto
    Pereira Lima, Roberto Cesar
    Tenazoa Wong, Deysi Viviana
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [43] Comprehensive kinome activity mapping of triple-negative breast cancer.
    Koemans, Nina M.
    Van der Borden, Carolien L.
    Mori, Miki
    Pan, Bo
    Wang, Changjun
    Van 't Veer, Laura J.
    Coppe, Jean-Philippe
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 44 - 44
  • [44] Association between obesity with disease-free survival and overall survival in triple-negative breast cancer: A meta-analysis
    Mei, Lin
    He, Lin
    Song, Yuhua
    Lv, Yang
    Zhang, Lijiu
    Hao, Fengxi
    Xu, Mengmeng
    MEDICINE, 2018, 97 (19)
  • [45] Lymphatic and vascular invasion patterns in triple-negative breast cancer.
    Yaman, S.
    Gumuskaya, B.
    Ozkan, C.
    Aksoy, S.
    Guler, G.
    Altundag, M. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [46] Chemotherapy-related outcomes in triple-negative breast cancer.
    Wellmann, Rebecca M.
    Ghafouri, Sanaz N.
    McAndrew, Nicholas Patrick
    Hurvitz, Sara A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] MYC as a therapeutic target for the treatment of triple-negative breast cancer.
    Foley, Sarah A.
    Casten, Alina
    Kavanagh, Emma
    Synnott, Naoise C.
    Crown, John
    Larsson, Lars-Gunnar
    Duffy, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer.
    O'Shaughnessy, Joyce
    Osborne, Cynthia
    Pippen, John E.
    Yoffe, Mark
    Patt, Debra
    Rocha, Christine
    Koo, Ingrid Chou
    Sherman, Barry M.
    Bradley, Charles
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (03): : 205 - 214
  • [49] Distinct immune microenvironments stratify triple-negative breast cancer.
    Gruosso, Tina
    Kumar, Venkata Satya
    Gigoux, Mathieu
    Saleh, Sadiq
    Bertos, Nicholas
    Omeroglu, Atilla
    Zuo, Dongmei
    Meterissian, Sarkis
    Haibe-Kains, Benjamin
    Park, Morag
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 17 - 17
  • [50] Targeting the RXR pathway for the prevention of triple-negative breast cancer.
    Moyer, Cassandra
    Hill, Jamal
    Coleman, Darian
    Sei, Shizuko
    Mohammed, Altaf
    Sanders, Martin
    Brown, Powel
    Mazumdar, Abhijit
    CANCER PREVENTION RESEARCH, 2023, 16 (01)
12345